Overview

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

Status:
Completed
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the rate and extent of absorption of venlafaxine hydrochloride 150 mg extended-release capsules (test) versus Effexor® XR (reference) administered as 1 x 150 mg extended-release capsule under fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Teva Pharmaceuticals USA
Treatments:
Venlafaxine Hydrochloride